Large scale generation and characterization of anti-human CD34 monoclonal antibody in ascetic fluid of balb/c mice

Advanced Pharmaceutical Bulletin

Volumn 3, Issue 1, 2013, Pages 211-216

  Maleki, Leili Aghebati ^a,b   Majidi, Jafar ^a,b   Baradaran, Behzad ^a,b   Abdolalizadeh, Jalal ^a   Kazemi, Tohid ^a,b   Maleki, Ali Aghebati ^a   Sepehr, Koushan Sineh ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ascetic fluid; Human CD34; Large scale generation; Monoclonal antibody

Indexed keywords

CD34 ANTIBODY; FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN KAPPA CHAIN; MONOCLONAL ANTIBODY;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANTIBODY ISOLATION; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; ASCITES FLUID; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PURIFICATION; SENSITIVITY AND SPECIFICITY;

EID: 84874963443     PISSN: 22285881     EISSN: 22517308     Source Type: Journal    
DOI: 10.5681/apb.2013.035     Document Type: Article

References (33)

1. Pandey SH. Hybridoma technology for production of monoclonal antibodies. Int J Pharm Sci Rev Res 2010;1(2): 88-94.
2. Hybridoma technology. [Online encyclopedia] USA: Wikipedia; [cited 2013 January]; Available from: http://en.wikipedia.org/wiki/Hybridoma_technology.
3. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975;256(5517):495-7.
4. Qian W, Wang L, Li B, Wang H, Hou S, Hong X, et al. Development of new versions of anti-human CD34 monoclonal antibodies with potentially reduced immunogenicity. Biochem Biophys Res Commun 2008;367(2):497-502.
5. Gunsilius E, Gastl G, Petzer AL. Hematopoietic stem cells. Biomed Pharmacother 2001;55(4):186-94.
6. Deterding LJ, Williams JG, Humble MM, Petrovich RM, Wei SJ, Trempus CS, et al. CD34 antigen: Determination of specific sites of phosphorylation in vitro and in vivo. Int J Mass spectrom 2011;301(1-3):12-21.
7. Krause DS, Fackler MJ, Civin CI, May WS. CD34: structure, biology, and clinical utility. Blood 1996;87(1):1-13.
8. Lanza F, Healy L, Sutherland DR. Structural and functional features of the CD34 antigen: an update. J Biol Regul Homeost Agents 2001;15(1):1-13.
9. Jackson LR, Trudel LJ, Fox JG, Lipman NS. Monoclonal antibody production in murine ascites. I. Clinical and pathologic features. Lab Anim Sci 1999;49(1):70-80.
10. Mc Ardle J. Alternatives to ascites production of monoclonal antibodies. Ani Welf Inform Cent Newslett 1998; 8: 3-4.
11. Lang AB, Schuerch U, Cryz SJ Jr. Optimization of growth and secretion of human monoclonal antibodies by hybridomas cultured in serum-free media. Hybridoma 1991;10(3):401-9.
12. Jackson LR, Trudel LJ, Fox JG, Lipman NS. Monoclonal antibody production in murine ascites. II. Production characteristics. Lab Anim Sci 1999;49(1):81-6.
13. Baradaran B, Majidi J, Hassan ZM, Abdolalizadeh J. Large scale production and characterization of anti- human IgG monoclonal antibody in peritoneum of Balb/c mice. Am J Biochem Biotechnol 2006;1(4):190-3.
14. Hadavi R, Zarnani AH, Ahmadvand N, Mahmoudi AR, Bayat AA, Mahmoudian J, et al. Production of Monoclonal Antibody against Human Nestin. Avicenna J Med Biotech 2010; 2(2): 69-76.
15. Thurston CF, Henle LF. New Protein Techniques. In: Walker JM, editor. Methods in Molecular Biology. Clifton NJ: The Humana Press Inc.; 1988. P. 149-58.
16. Harlow E, Lane D. Labeling antibodies with fluorochromes. CSH protocols 2006;2006(2).
17. Tabatabaei-Panah AS, Zarnani AH, Montaser-Kouhsar Sh, Chamankhah M, Ghods R, Bayat AA, et al. Production and Characterization of Anti-Her2 Monoclonal Antibodies. Yakhteh Med J 2008;10(2):109-20.
18. Robinson M, Weiner L, Adams G. Improving Monoclonal Antibodies for Cancer Therapy. Drug Dev Res 2004;61:172-87.
19. Schrama D, Reisfeld R, Becker J. Antibody targeted drugs as cancer therapeutics. Annu Rev Med 2006; 5: 174-90.
20. Enever C, Batuwangala T, Plummer C, Sepp A. Next generation immunotherapeutics--honing the magic bullet. Curr Opin Biotechnol 2009;20(4):405-11.
21. Modjtahedi H. Monoclonal Antibodies as Therapeutic Agents: Advances and Challenges. Iran J Immunol 2005;2(1):3-21.
22. Fitzgerald J, Leonard P, Darcy E, O'Kennedy R. Immunoaffinity chromatography. Methods Mol Biol 2011;681:35-59.
23. Peterson NC, Peavey JE. Comparison of in vitro monoclonal antibody production methods with an in vivo ascites production technique. Contemp Top Lab Anim Sci 1998;37(5):61-6.
24. Walvoort NC. Assessment of distress through pathological examination. In: Hendriksen CFM, Köeter HBWM, editors. Replacement, Reduction and Refinement: Present Possibilities and Future Prospects. Amsterdam: Elsevier; 1991. P. 265-73.
25. Leenaars M, Hendriksen CF. Critical steps in the production of polyclonal and monoclonal antibodies: evaluation and recommendations. ILAR J 2005;46(3):269-79.
26. Peterson NC. Advances in monoclonal antibody technology: genetic engineering of mice, cells, and immunoglobulins. ILAR J 2005;46(3):314-9.
27. Peterson NC. Behavioral, clinical, and physiologic analysis of mice used for ascites monoclonal antibody production. Comp Med 2000;50(5):516-26.
28. Mauch P,Ultmann. Treatment of malignant ascites. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice of Oncology. Philadelphia: Lippincott; 1985. P. 2150-3.
29. Baradaran B, Hosseini AZ, Majidi J, Farajnia S, Barar J, Saraf ZH, et al. Development and characterization of monoclonal antibodies against human epidermal growth factor receptor in Balb/c mice. Hum Antibodies 2009;18(1-2):11-6.
30. Hafley BS. Development of Monoclonal Antibodies for a Multiple Antigen ELISA to Verify Safe Cooking End-Point Temperatures in Beef and Pork [PhD Dissertation]. USA: Texas A&M University; 2005.
31. Tadjine M, Mittal KR, Bourdon S, Gottschalk M. Production and characterization of murine monoclonal antibodies against Haemophilus parasuis and study of their protective role in mice. Microbiology 2004;150(Pt 12):3935-45.
32. Galen FX, Devaux C, Atlas S, Guyenne T, Menard J, Corvol P, et al. New monoclonal antibodies directed against human renin. Powerful tools for the investigation of the renin system. J Clin Invest 1984;74(3):723-35.
33. Chou SF, Hsu WL, Hwang JM, Chen CY. Production of monoclonal and polyclonal antibodies against human alphafetoprotein, a hepatocellular tumor marker. Hybrid Hybridomics 2002;21(4):301-5.